tiprankstipranks
Airsculpt Technologies, Inc. (AIRS)
NASDAQ:AIRS
US Market
Holding AIRS?
Track your performance easily

Airsculpt Technologies, Inc. (AIRS) Stock Price & Analysis

46 Followers

AIRS Stock Chart & Stats


Bulls Say, Bears Say

Bulls Say
Expansion PotentialWith just 31 active centers, AirSculpt can continue to open new sites in untapped markets.
Financial PerformanceAIRS previewed 3Q results with a 2%+ beat on revenues.
Operational EfficiencyReturning to 30% EBITDA margins is achievable.
Bears Say
EarningsAIRS previewed very disappointing results, missing EBITDA expectations by 70% and falling well below the company's full-year guidance range.
Financial PerformanceEBITDA declined nearly 84% on a year-over-year basis, with margins continuing to drop sequentially from 11% to 4.2%.
Market DemandCase volumes at mature centers have steadily declined as consumers pulled back spending on medical aesthetics and cosmetic surgery.
---

Financials

Annual

Ownership Overview

27.97%1.69%59.04%9.18%
27.97% Insiders
59.04% Other Institutional Investors
9.18% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

AIRS FAQ

What was Airsculpt Technologies, Inc.’s price range in the past 12 months?
Airsculpt Technologies, Inc. lowest stock price was $2.92 and its highest was $9.20 in the past 12 months.
    What is Airsculpt Technologies, Inc.’s market cap?
    Airsculpt Technologies, Inc.’s market cap is $295.78M.
      When is Airsculpt Technologies, Inc.’s upcoming earnings report date?
      Airsculpt Technologies, Inc.’s upcoming earnings report date is Mar 07, 2025 which is in 37 days.
        How were Airsculpt Technologies, Inc.’s earnings last quarter?
        Airsculpt Technologies, Inc. released its earnings results on Nov 08, 2024. The company reported -$0.02 earnings per share for the quarter, missing the consensus estimate of -$0.003 by -$0.017.
          Is Airsculpt Technologies, Inc. overvalued?
          According to Wall Street analysts Airsculpt Technologies, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Airsculpt Technologies, Inc. pay dividends?
            Airsculpt Technologies, Inc. pays a Notavailable dividend of $0.409 which represents an annual dividend yield of N/A. See more information on Airsculpt Technologies, Inc. dividends here
              What is Airsculpt Technologies, Inc.’s EPS estimate?
              Airsculpt Technologies, Inc.’s EPS estimate is <0.01.
                How many shares outstanding does Airsculpt Technologies, Inc. have?
                Airsculpt Technologies, Inc. has 57,882,282 shares outstanding.
                  What happened to Airsculpt Technologies, Inc.’s price movement after its last earnings report?
                  Airsculpt Technologies, Inc. reported an EPS of -$0.02 in its last earnings report, missing expectations of -$0.003. Following the earnings report the stock price went up 20.723%.
                    Which hedge fund is a major shareholder of Airsculpt Technologies, Inc.?
                    Among the largest hedge funds holding Airsculpt Technologies, Inc.’s share is Bandera Partners. It holds Airsculpt Technologies, Inc.’s shares valued at 785K.
                      ---

                      Company Description

                      Airsculpt Technologies, Inc.

                      AirSculpt Technologies Inc is a provider of body contouring procedures delivering a premium consumer experience. It provides a custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure, producing dramatic results. Its mission is to generate the best results for patients.
                      ---

                      AIRS Earnings Call

                      Q3 2024
                      0:00 / 0:00
                      Earnings Call Sentiment|Neutral
                      The earnings call presented a mixed picture with strategic expansions and cost-saving measures being positive aspects. However, significant declines in revenue, higher costs, and reduced profitability highlight challenges in the current economic environment.Read More>
                      ---
                      Similar Stocks
                      Company
                      Price & Change
                      Follow
                      Anika Therapeutics
                      Cutera
                      Avita Medical
                      Viveve Medical
                      Evolus
                      Popular Stocks
                      ---
                      What am I Missing?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis